Molecular Genetics of Successful Smoking Cessation

Bupropion Nicotine replacement therapy Genome-wide Association Study
DOI: 10.1001/archpsyc.65.6.683 Publication Date: 2008-06-02T23:11:56Z
ABSTRACT
<h3>Context</h3> Smoking remains a major public health problem. Twin studies indicate that the ability to quit smoking is substantially heritable, with genetics overlap modestly of vulnerability dependence on addictive substances. <h3>Objectives</h3> To identify replicated genes facilitate smokers' abilities achieve and sustain abstinence from (hereinafter referred as quit-success genes) found in more than 2 genome-wide association (GWA) successful vs unsuccessful abstainers, and, secondarily, nominate for selective involvement cessation success bupropion hydrochloride nicotine replacement therapy (NRT). <h3>Design</h3> The GWA results subjects 3 centers, secondary analyses NRT responders. <h3>Setting</h3> Outpatient trial participants centers. <h3>Participants</h3> European American smokers who successfully unsuccessfully abstain biochemical confirmation using NRT, bupropion, or placebo (N = 550). <h3>Main Outcome Measures</h3> Quit-success genes, reproducibly identified by clustered nominally positive single-nucleotide polymorphisms (SNPs) independent samples significant<i>P</i>values based Monte Carlo simulation trials. NRT-selective were nominated SNPs display much larger<i>t</i>values comparisons. bupropion-selective results. <h3>Results</h3> Variants are likely alter cell adhesion, enzymatic, transcriptional, structural, DNA, RNA, and/or protein-handling functions. unlikely represent chance observations (Monte Carlo<i>P</i>&lt; .0003). These modest substances memory. <h3>Conclusions</h3> support polygenic abstaining smoking, substance memory, gene variants influences therapeutic responses NRT. Molecular should help match types intensity antismoking treatments most benefit them.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (210)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....